Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Andelman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annals of the Rheumatic Diseases|October 1, 1993
RhazesY Andelman
Clinical Therapeutics|January 1, 1983
Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week studyS Y Andelman
Journal of Clinical Pharmacology|May 1, 1980
Long-term safety of zomepirac: a double-blind comparison with aspirin in patients with osteoarthritisG E Ruoff, S Y Andelman, J J Cannella
Clinical Pharmacology and Therapeutics|September 1, 1977
A multicenter trial of sulindac in osteoarthritis of the hipJ J Calabro, S Y Andelman, J R Caldwell, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annals of the Rheumatic Diseases|October 1, 1993
RhazesY Andelman
Clinical Therapeutics|January 1, 1983
Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week studyS Y Andelman
Journal of Clinical Pharmacology|May 1, 1980
Long-term safety of zomepirac: a double-blind comparison with aspirin in patients with osteoarthritisG E Ruoff, S Y Andelman, J J Cannella
Clinical Pharmacology and Therapeutics|September 1, 1977
A multicenter trial of sulindac in osteoarthritis of the hipJ J Calabro, S Y Andelman, J R Caldwell, et al.
Pageof 1